Literature DB >> 17038816

[Influenza virus receptors in the human airway].

Kyoko Shinya1, Yoshihiro Kawaoka.   

Abstract

Avian influenza A (H5N1) virus infections have resulted in more than 100 human deaths; yet, human-to-human transmission is rare. We demonstrated that the epithelial cells in the upper respiratory tract of humans mainly possess sialic acid linked to galactose by alpha 2,6 linkages (SA alpha 2,6Gal), a molecule preferentially recognized by human viruses. However, many cells in the respiratory bronchioles and alveoli possess SA alpha 2,3Gal, which is preferentially recognized by avian viruses. These facts are consistent with the observation that H5N1 viruses can be directly transmitted from birds to humans and cause serious lower respiratory tract damage in humans. Furthermore, this anatomical difference in receptor prevalence may explain why the spread of H5N1 viruses among humans is limited. However, since some H5N1 viruses isolated from humans recognize human virus receptors, additional changes must be required for these viruses to acquire the ability for efficient human-to-human transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038816     DOI: 10.2222/jsv.56.85

Source DB:  PubMed          Journal:  Uirusu        ISSN: 0042-6857


  9 in total

1.  Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.

Authors:  Xuxiao Zhang; Juan Pu; Yipeng Sun; Bi Yuhai; Zhimin Jiang; Guanlong Xu; Hongyu Zhang; Jing Cao; Kin-Chow Chang; Jinhua Liu; Honglei Sun
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

2.  Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

Authors:  Wendy C L Yu; Renee W Y Chan; Jieru Wang; Emily A Travanty; John M Nicholls; J S Malik Peiris; Robert J Mason; Michael C W Chan
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

3.  Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air.

Authors:  Neal Van Hoeven; Claudia Pappas; Jessica A Belser; Taronna R Maines; Hui Zeng; Adolfo García-Sastre; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

4.  Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia.

Authors:  Joon Y Song; Hee J Cheong; Jung Y Heo; Ji Y Noh; Hwan S Yong; Yoon K Kim; Eun Y Kang; Won S Choi; Yu M Jo; Woo J Kim
Journal:  Influenza Other Respir Viruses       Date:  2011-06-20       Impact factor: 4.380

5.  H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.

Authors:  Sook-San Wong; Jennifer DeBeauchamp; Mark Zanin; Yilun Sun; Li Tang; Richard Webby
Journal:  NPJ Vaccines       Date:  2017-06-08       Impact factor: 7.344

Review 6.  Virus-Receptor Interactions: The Key to Cellular Invasion.

Authors:  Melissa S Maginnis
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

7.  SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.

Authors:  Ying Huang; Amanda L Skarlupka; Hyesun Jang; Uriel Blas-Machado; Nathan Holladay; R Jeffrey Hogan; Ted M Ross
Journal:  J Virol       Date:  2021-12-22       Impact factor: 5.103

8.  Influenza Viruses Suitable for Studies in Syrian Hamsters.

Authors:  Shufang Fan; Chunyang Gu; Huihui Kong; Lizheng Guan; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

Review 9.  Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.

Authors:  Hanaa Ahmed-Hassan; Brianna Sisson; Rajni Kant Shukla; Yasasvi Wijewantha; Nicholas T Funderburg; Zihai Li; Don Hayes; Thorsten Demberg; Namal P M Liyanage
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.